PSA
56
5
BA
49
-3
CRM
65
6
ORCL
67
2
THC
55
-4
HBAN
56
2
FTI
76
3
ISRG
76
2
GWW
71
4
EXC
56
2
FMC
33
2
USB
61
11
PWR
72
2
LMT
32
-12
UA
59
14
STI
31
-16
FRT
45
6
DOW
34
4
DE
56
10
CVX
44
-2
PSA
56
5
BA
49
-3
CRM
65
6
ORCL
67
2
THC
55
-4
HBAN
56
2
FTI
76
3
ISRG
76
2
GWW
71
4
EXC
56
2
FMC
33
2
USB
61
11
PWR
72
2
LMT
32
-12
UA
59
14
STI
31
-16
FRT
45
6
DOW
34
4
DE
56
10
CVX
44
-2
Financhill
Back

Recursion Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44

RXRX
Recursion Pharmaceuticals

Last Price:
5.80
Seasonality Move:
6.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

Recursion Pharmaceuticals Price Quote

$5.80
+0.05 (+0.87%)
(Updated: November 22, 2024 at 2:10 PM ET)

Recursion Pharmaceuticals Key Stats

Sell
44
Recursion Pharmaceuticals (RXRX) is a Sell
Day range:
$5.62 - $6.03
52-week range:
$5.62 - $15.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21.87
P/B ratio:
3.14%
Volume:
12.3M
Avg. volume:
6.2M
1-year change:
-12.08%
Market cap:
$1.6B
Revenue:
$43.9M
EPS:
$-1.55

How Much Does Recursion Pharmaceuticals Make?

Is Recursion Pharmaceuticals Growing As A Company?

Recursion Pharmaceuticals Stock Price Performance

What Is Recursion Pharmaceuticals 52-Week High & Low?

Recursion Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Recursion Pharmaceuticals?

Is Recursion Pharmaceuticals Cash Flow Positive?

  • What Is RXRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$317.8M
  • What Is Recursion Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $374.1M
  • What Is Recursion Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$17.9M

Recursion Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    RXRX return on invested capital is -76.3%
  • What Is Recursion Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -56.47%
  • What Is RXRX Return On Equity?
    ROE is a measure of profitability and is -78.32%

Recursion Pharmaceuticals Earnings Date & Stock Price

Recursion Pharmaceuticals Competitors

Recursion Pharmaceuticals Dividend Yield

Recursion Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -2.15%
Revenue: 158.19% -12.56%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 9.86
Upside from Last Price: 71.43%

Major Shareholders

  • How many RXRX shares are owned by institutional investors?
    388.9M RXRX shares are owned by institutional investors
  • How many RXRX shares are owned by insiders?
    11.2M RXRX shares are owned by insiders